Announcement on Implementation of Dividend Distribution for 2025
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Implementation of Dividend Distribution for 2025
Filed with SSE · · 3 pages · Chinese
Summary by 6ix AI
The distribution plan was approved at the annual shareholders' meeting held in June of the following year. The announcement includes information on the dividend payment method and tax implications for different types of shareholders. Shareholders are advised on how to receive their dividends and the applicable tax rates based on their holding periods.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Release
Mayinglong Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Mayinglong Pharmaceutical
- Announcement on the Listing and Trading of Restricted Shares from the Share Reform
- Announcement on Obtaining Drug Registration Certificate by Subsidiary
- Announcement on the Inclusion of the Company's Pharmaceutical Products in the "National Essential Medicines List"
- Announcement on Attending the 2026 Collective Reception Day for Investors of Listed Companies in Hubei Jurisdiction
- Announcement on Obtaining Drug Registration Certificate
Later from Mayinglong Pharmaceutical
- Announcement on Departure and Appointment of General Manager
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- (600993)"Mayinglong Pharmaceutical Group Co., Ltd."Report for Q3 2026
Follow Mayinglong Pharmaceutical into a list and get an email when it puts out news.
Follow Mayinglong Pharmaceutical